RA Capital Management’s Amgen AMGN Stock Holding History

RA Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,900	Closed	-$906K	–	52
2015 Q2	$906K	Hold	5,900	–	–	0.09%	56
2015 Q1	$943K	Hold	5,900	–	–	0.09%	53
2014 Q4	$940K	Hold	5,900	–	–	0.1%	44
2014 Q3	$829K	Buy	+5,900	New	+$770K	0.1%	39

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RA Capital Management's AMGN Position: Q3 2015 in Review

RA Capital Management sold out of Amgen (AMGN) in Q3 2015, closing a stake of 5,900 shares — an estimated $906K sold.

RA Capital Management first reported a position in AMGN in Q3 2014 and held it in 4 quarters. The position peaked at $943K in Q1 2015. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

RA Capital Management reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
RA Capital Management sold 5,900 Amgen shares in Q3 2015, an estimated $906K.
RA Capital Management first reported a position in Amgen in Q3 2014 and held it in 4 quarters.
RA Capital Management's Amgen position peaked at $943K in Q1 2015.
1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on RA Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.